Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Energy Vault Holdings Reports Quarterly Losses and Sales Miss But Sees Impressive YearOverYear Revenue Growth

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Energy Company Markets and money
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Energy Vault Holdings (NYSE:NRGV) announced quarterly losses of $(0.15) per share on March 12, 2024, which was slightly lower than the analyst consensus estimate of $(0.14) by 7.14%. This quarter saw an 11.76% increase in losses compared to the same period last year.

The company’s quarterly sales for the same period were reported at $118.236 million, missing the analyst consensus estimate of $151.496 million by 21.95%. Despite falling short of expectations, this represents a 17.86% increase in sales over the same period last year.

Looking at the full year, Energy Vault’s revenue reached $341.5 million, marking an impressive 134% year-over-year increase in earnings.

NRGV Stock Price Drops 7.65% on March 12, 2024: What Investors Need to Know

On March 12, 2024, NRGV stock experienced a significant drop in its price, closing at $1.81, which was a decrease of $0.15 or 7.65% from the previous market close. Despite the drop during regular trading hours, NRGV saw a slight uptick in after-hours trading, with the stock rising by $0.04. Investors in NRGV should closely monitor the stock’s performance in the coming days to assess whether the recent price drop is a temporary setback or a sign of a longer-term trend. Factors such as market conditions, company news, and industry trends can all impact the stock’s performance. Consulting with a financial advisor or conducting your own due diligence can help investors make informed choices and navigate the ups and downs of the stock market.

NRGV Stock Performance Analysis: Net Income Declines by 2245.31% Year-Over-Year

On March 12, 2024, investors in NRGV stock were closely watching the company’s performance, particularly in terms of its net income and earnings per share. According to data from CNN Money, NRGV reported a net income of -$78.30 million over the past year, which represented a significant decrease of 2245.31% compared to the previous year. However, there was a slight improvement in net income from the third quarter, with a decrease of 27.6%.

Similarly, the earnings per share (EPS) for NRGV also showed a decline over the past year, with a reported EPS of -$0.64, representing a decrease of 583.85% compared to the previous year. On a more positive note, the EPS improved by 28.15% from the third quarter.

Tags: NRGV
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

inTEST Corporation Acquires Alfamation SpA to Strengthen Market Presence and Expand Test Offerings

Finance_ Chart Down

Coinbase Global Inc Announces 1 Billion Convertible Senior Notes Offering

Promising Results of Phase 2 Trial for Paltusotine in Treating Carcinoid Syndrome

Recommended

Biotechnology Stock Exchange

Analysts Bullish on Dynatrace with Price Targets on the Rise

2 years ago
The Trade Desk Stock

The Trade Desk Faces Mounting Pressure as Amazon Strikes Netflix Deal

5 months ago

Analyst Reaffirms Buy Rating on International Seaways with 66 Price Target

2 years ago
Biotechnology Stock Bull Market

KeyBanc Analyst Raises Price Target and Maintains Overweight Rating on Repligen NASDAQ RGEN

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Trending

Puma Biotechnology Stock
Earnings

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

by Jackson Burston
February 8, 2026
0

Investor attention is now firmly fixed on February 26, 2026, as Puma Biotechnology prepares to release its...

Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test
  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com